価格表

在庫・価格 : 2025年10月08日 09時04分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human CXCL1/GRO alpha MAb (Clone 20326)
データシート※最新のデータシートでない場合があります
MAB275-SP RSDアールアンドディー システムズ
R&D Systems, Inc.
25 μg ¥28,000 1個 追加

在庫・価格 : 2025年10月08日 09時04分 現在

Anti-Human CXCL1/GRO alpha MAb (Clone 20326)

  • 商品コード:MAB275-SP
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥28,000
  • 在庫:1個
使用文献
No. 文献情報 備考 参照
1 Fong L et al. Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer. Cancer Discov 2020 01;10(1):40-53
Fong L et al
2020/01/01
Species: Human, Applications: Flow Cytometry PubMed
2 Flaherty E et al. Neuronal impact of patient-specific aberrant NRXN1α splicing. Nat Genet 2019 12;51(12):1679-1690
Flaherty E et al
2019/01/01
Species: Human, Applications: Flow Cytometry PubMed
3 Kitawaki Y et al. Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma. Hum Pathol 2018 07;77:88-97
Kitawaki Y et al
2018/01/01
Species: Human, Applications: IHC-P PubMed
4 Ashander LM et al. Neutrophil Activities in Human Ocular Toxoplasmosis: An In Vitro Study With Human Cells. Invest Ophthalmol Vis Sci 2019 11;60(14):4652-4660
Ashander LM et al
2019/01/01
Species: Human, Applications: Neutralization PubMed
5 Gelderblom M et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 2012 Nov;120(18):3793-802
Gelderblom M et al
2012/01/01
Species: Human, Applications: IHC-P PubMed
6 Logue SE et al. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun 2018 08;9(1):3267
Logue SE et al
2018/01/01
Species: Human, Applications: Neutralization PubMed
7 Numasaki M et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J. Immunol. 2005 Nov;175(9):6177-89
Numasaki M et al
2005/01/01
Species: Human, Applications: Neutralization PubMed
8 Meen AJ et al. Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J. Biol. Chem. 2011 Jan;286(4):2636-47
Meen AJ et al
2011/01/01
Species: Human, Applications: ICC PubMed
9 Moscova M et al. Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines. Cancer Res. 2006 Feb;66(3):1376-83
Moscova M et al
2006/01/01
Species: Human, Applications: Immunodepletion PubMed
10 Oladipo O et al. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. Br. J. Cancer 2011 Feb;104(3):480-7
Oladipo O et al
2011/01/01
Species: Human, Applications: IHC-P PubMed
11 Kim EK et al. CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma. PLoS ONE 2018;13(1):e0188847
Kim EK et al
2018/01/01
Species: Human, Applications: Neutralization PubMed
12 Henry CM et al. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation. Mol. Cell 2017 Feb;65(4):715-729.e5
Henry CM et al
2017/01/01
Species: Human, Applications: ICC PubMed
13 Chan TS et al. Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells. J. Exp. Med. 2016 12;213(13):2967-2988
Chan TS et al
2016/01/01
Species: Human, Applications: Neutralization PubMed
14 Hagiwara H et al. Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells. Circulation 1998 Dec;98(23):2584-90
Hagiwara H et al
1998/01/01
Species: Human, Applications: Western Blot PubMed
  • No.: 1
  • 文献情報:
    Fong L et al. Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer. Cancer Discov 2020 01;10(1):40-53
    Fong L et al
    2020/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Flaherty E et al. Neuronal impact of patient-specific aberrant NRXN1α splicing. Nat Genet 2019 12;51(12):1679-1690
    Flaherty E et al
    2019/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Kitawaki Y et al. Tumor microenvironment in functional adrenocortical adenomas: immune cell infiltration in cortisol-producing adrenocortical adenoma. Hum Pathol 2018 07;77:88-97
    Kitawaki Y et al
    2018/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Ashander LM et al. Neutrophil Activities in Human Ocular Toxoplasmosis: An In Vitro Study With Human Cells. Invest Ophthalmol Vis Sci 2019 11;60(14):4652-4660
    Ashander LM et al
    2019/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Gelderblom M et al. Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke. Blood 2012 Nov;120(18):3793-802
    Gelderblom M et al
    2012/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Logue SE et al. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun 2018 08;9(1):3267
    Logue SE et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Numasaki M et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J. Immunol. 2005 Nov;175(9):6177-89
    Numasaki M et al
    2005/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Meen AJ et al. Serglycin is a major proteoglycan in polarized human endothelial cells and is implicated in the secretion of the chemokine GROalpha/CXCL1. J. Biol. Chem. 2011 Jan;286(4):2636-47
    Meen AJ et al
    2011/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Moscova M et al. Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines. Cancer Res. 2006 Feb;66(3):1376-83
    Moscova M et al
    2006/01/01
  • 備考:
    Species: Human, Applications: Immunodepletion
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Oladipo O et al. The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue. Br. J. Cancer 2011 Feb;104(3):480-7
    Oladipo O et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Kim EK et al. CXCL1 induces senescence of cancer-associated fibroblasts via autocrine loops in oral squamous cell carcinoma. PLoS ONE 2018;13(1):e0188847
    Kim EK et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Henry CM et al. Caspase-8 Acts in a Non-enzymatic Role as a Scaffold for Assembly of a Pro-inflammatory "FADDosome" Complex upon TRAIL Stimulation. Mol. Cell 2017 Feb;65(4):715-729.e5
    Henry CM et al
    2017/01/01
  • 備考:
    Species: Human, Applications: ICC
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Chan TS et al. Metronomic chemotherapy prevents therapy-induced stromal activation and induction of tumor-initiating cells. J. Exp. Med. 2016 12;213(13):2967-2988
    Chan TS et al
    2016/01/01
  • 備考:
    Species: Human, Applications: Neutralization
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Hagiwara H et al. Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells. Circulation 1998 Dec;98(23):2584-90
    Hagiwara H et al
    1998/01/01
  • 備考:
    Species: Human, Applications: Western Blot
  • 参照:
    PubMed